Elon's Next Market Move Could Send Silver Soaring

Every industry Elon Musk touches explodes—from Tesla to SpaceX to AI.

And now, whispers are growing that his next move could be in silver.

Why? Because silver is the lifeblood of EVs, solar panels, and AI tech.

Without it, Tesla, SpaceX, and Starlink don't grow.

Even back in 2022, Musk hinted at Tesla entering the mining industry. And with new policies clearing the way, the timing couldn't be better.

What happens if Elon enters silver?

Massive supply chain disruptions – Silver demand is already outpacing supply.
Prices could surge overnight – Even rumors of Musk in silver could send markets flying.
A historic opportunity – Investors who act before the headlines could be in for a massive windfall.

Smart money is already watching silver closely.

That's why we put together the 2026 Silver Forecast Guide—your roadmap to silver's biggest growth phase yet.

Click Here to Get your Free Copy Before Silver Moves >>

Because once Musk makes a move, the window to act disappears.

This Week's Bonus News

Oklo: The Bottom Is In, and the Upside Potential Is Nuclear

Reported by Thomas Hughes. Originally Published: 3/19/2026.

Key Points

Oklo's FY2025 update revealed progress, and the market liked it; the diversification strategy is progressing.
Analysts responded favorably, affirming the forecast for a 50% stock price increase.
Short-covering and institutional accumulation align with a technical bottom, setting this market up to sustain a rebound in 2026.
Special Report: The Biggest IPO Ever: Claim Your Stake Today

Oklo Inc. (NYSE: OKLO) faces headwinds, including a lack of revenue and profits, but that hasn't slowed investor interest. The company's fiscal 2025 (FY2025) progress report and updates indicate it is on track to meet long-term goals and market expectations. The market response — including analyst updates after the release — reflects that sentiment: near-term revenue isn't the focus given the long-term opportunity.

Analysts Focus on Oklo's Long-Term Opportunity

MarketBeat tracked about half a dozen revisions within the first 12 hours after the release. Those included a single price-target reduction offset by a larger number of affirmed ratings and targets, and there were no downgrades.

Why the Fed's new 24/7 banking system is a trap (Ad)

The Federal Reserve is selling banks their new FedNow system with one major promise: transfers will happen instantly, 24/7/365 with no more weekend or holiday delays—but when your money moves instantly through a centralized government hub, it can also be frozen instantly by automated algorithms inside the Fed's new network. Imagine it's 6:00 p.m. on a Friday when your account is instantly locked by a faceless government computer in Washington because an algorithm flagged a recent purchase or donation as suspicious, cutting you off from your own money until Monday morning or later with no way to pay for anything.

Get the 4 steps to Fed-proof your savings now

The activity is consistent with the broader trend: expanding coverage, a steady Moderate Buy rating, a 58% buy-side bias, and rising price targets. Consensus price targets imply more than 50% upside relative to mid-March lows, which is a key element driving interest.

Although analysts expressed concern about the 2025 results, they remain focused on the long-term opportunity and progress in Nuclear Regulatory Commission licensing.

The company received its first license through subsidiary Atomic Alchemy, which produces isotopes. The license permits the receiving, possession, storage, processing, repackaging, and distribution of up to two curies of radium-226 — roughly two grams.

Two grams isn't much, and radium-226 isn't especially valuable on its own. Once used in medicines, it is now costly to handle and remediate. However, radium-226 is increasingly important as a source material for actinium, which is used in specialized cancer treatments and can command prices that translate to roughly $20,000 per dose.

The takeaway for investors is that Oklo's diversification strategy has been validated and a revenue stream has been opened. It may take a few quarters for meaningful revenue to appear, but that income could arrive well before commercialization of its core nuclear reactor technologies.

Institutional and Short-Selling Data Reveal the Bottom Is In for Oklo Stock

Institutional and short-selling data suggest a bottom for Oklo shares. Short interest remains high — near 15% as of early March — but it has fallen from its peak recorded around the company's October 2025 highs and is likely to keep declining in upcoming reports. Institutional activity has moved in the opposite direction, accelerating after Oklo's Q2 2025 plunge and reaching record levels in early 2026.

Institutions now own roughly 85% of the stock, providing solid support, and are accumulating at an estimated ratio of about $3 bought for every $1 sold. If these trends persist, the number of shares available to trade could fall substantially in the coming months, making upward price moves more likely. A catalytic news event could even trigger a short squeeze.

Dilutive Headwinds Ease in 2026

Shareholder dilution was a material factor in 2025, but the situation looks better in 2026. The company's share count is up roughly 50% year over year, and the balance sheet appears well capitalized. FY2026 plans suggest the company has sufficient capital to fund operations at the current burn rate for about two years, providing a window for secondary revenue streams — like the isotope business — to develop. However, profitability isn't expected until 2030, so additional capital will likely be required down the road.

The technical setup also looks constructive. OKLO's stock is well off its highs but showed an overextended move in March. The MACD has turned bullish, and the stochastic indicator has followed, signaling a strong buy at these levels. Whether the market follows through on these indicators may take time; the absence of revenue and profits remains a significant headwind.

The biggest risk is execution and delay. The market is pricing in robust growth, valuing the stock at more than 100x projected initial-year earnings, and may react sharply to setbacks. In that scenario, Oklo could face heightened volatility whether the rebound arrives sooner or later.

Today's Featured Story

SERV Robotics Delivers Catalyst for Short-Squeeze

Author: Thomas Hughes. Posted: 3/11/2026.

Key Points

SERV Robotics is rapidly expanding its services and is on track to continue at a robust pace in 2026.
Analysts and institutions indicate accumulation, providing solid support and a market tailwind.
Short interest is high, setting the stage for a squeeze that could take this market to a fresh long-term high.
Special Report: The Biggest IPO Ever: Claim Your Stake Today

Serve Robotics (NASDAQ: SERV) delivered a solid fiscal Q4 2025 report, enough to spark a steep increase in its share price and, potentially, a short squeeze. Expansion is well underway, progressing faster than anticipated, and is expected to continue in 2026.

Among the takeaways is Serve Robotics' expanding presence — not only in city count but also in active robots, clients, and foodservice platforms. The Q4 release included updates such as White Castle's entry into the portfolio, expanded delivery verticals, and broader partnerships with Uber Eats (NYSE: UBER) and DoorDash (NASDAQ: DASH), all of which represent tailwinds for revenue growth.

High-Short Interest Sets SERV Up for Rally and Squeeze

Why the Fed's new 24/7 banking system is a trap (Ad)

Get the 4 steps to Fed-proof your savings now

Short interest is a factor that should not be ignored, as it represents both risk and opportunity for investors. The risk is that short-sellers are right: SERV Robotics is overhyped and its shares fall. The upside is that 29% short interest, coupled with solid results and a rapidly improving outlook, could catalyze a short squeeze, driving prices higher and forcing shorts to cover.

In this scenario — and MarketBeat's short-seller data suggests it may already be unfolding — short sellers could start to cover their bets en masse, triggering a rapid share price increase. As it stands, 6.1 days to cover suggests short covering could produce a meaningful move higher.

Analysts expressed caution after SERV's guidance update, but there were no immediate revisions to consensus estimates. Concern centers on cash burn, which is forecast to roughly match revenue in 2026.

That cash draw could be offset by operational progress and rapid growth. Consensus forecasts a hypergrowth trajectory over the next five to six years — with high triple-digit revenue growth in 2026, slowing to lower triple-digit growth in 2027, and high-double-digit growth thereafter.

The guidance underscores the risk: the company plans roughly $25 million in CapEx against about $26 million in expected revenue. The clear impact will be on the balance sheet, including reduced cash and the potential for equity erosion and dilution. As of now, the company holds about $260 million in liquid assets, but that capitalization came at a cost — the share count doubled over the past year, which provided an opening for short sellers to push the stock lower.

Assuming no further dilution, short-sellers may be more likely to cover than not, but capitalization remains questionable. Additional funding will likely be necessary as the company pursues expansion. Analysts expect profitability only early in the next decade, implying that one or several capital injections could be required before growth becomes self-sustaining.

Institutions Support SERV Stock, Accumulate Aggressively in Q1 2026

While short-sellers have been selling into the market, institutions have been accumulating shares. The group owns roughly 40% of the stock, buying at a rate greater than $2-to-$1 on a trailing-12-month (TTM) basis, with activity ramping in early 2026.

Early Q1 2026 data reflect more than $10 bought for every $1 sold, indicating a solid support base and a market tailwind. This institutional appetite for SERV could amplify short-covering, leading to outsized, accelerated price moves.

The market responded favorably to the news. The share price jumped about 10% in pre-market trading, then added roughly another 10 percentage points after the open. The move establishes support at a critical level, lifts the stock above its cluster of moving averages, and sets the stage for further gains. Near-term resistance sits at $14.15 and could be reached before mid-year, if not sooner.

Analysts are broadly bullish on SERV despite some caution. MarketBeat's data shows coverage expanding to nine analysts on a trailing 12-month basis, sentiment firming to "Strong Buy," an 87.5% buy-side bias, and an upward trend in the price target.

The price target is the key focus in March, as it implies roughly 65% upside from the pre-release close and would represent a one-year high if reached. Upcoming catalysts include the potential to outperform guidance, aided by recent acquisitions. The purchase of Diligent Robotics diversifies the business beyond sidewalk deliveries into in-house hospital services and, potentially, other service areas.

Thank you for subscribing to TickerReport, where we work around-the-clock
to bring you the latest market-moving news.

This email message is a sponsored email provided by Priority Gold, a third-party advertiser of TickerReport and MarketBeat.

Contact Us | Unsubscribe

© 2006-2026 MarketBeat Media, LLC dba TickerReport. All rights protected.
345 N Reid Place, Sixth Floor, Sioux Falls, S.D. 57103. U.S.A..